Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

References

• The Seventh report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood pressure. JNC 7Hypertension2003421206125214656957
   PubMed Web of Science ®Google Scholar
• OngKLCheungBMYManYBPrevalence, awareness, treatment, and control of hypertension among United States adults, 1999–2004Hypertension200749697517159087
   PubMed Web of Science ®Google Scholar
• RosasMLaraAPastelínGVelásquezOMartínezJMendezARe-encuesta nacional de hipertensión arterial. Consolidación Mexicana de los factores de riesgo cardiovascular. Cohorte Nacional de SeguimientoArch Cardiol Mex2005759611115909748
   PubMedGoogle Scholar
• PimentaEOparilSFixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combinationVasc Health Risk Manag2008465366418827915
   PubMedGoogle Scholar
• WaldDSLawMMorrisJKBestwickJPWaldNJCombination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trialsAm J Med200912229030019272490
   PubMed Web of Science ®Google Scholar
• BakrisGLCombined therapy with a calcium channel blocker and an angiotensin ii type 1 receptor blockerJ Clin Hypertens2008101 Suppl 12732
   Web of Science ®Google Scholar
• The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of CardiologyGuidelines for the management of arterial hypertensionJ Hypertens200725105188
   Web of Science ®Google Scholar
• DahlöfBManagement of cardiovascular risk with RAS inhibitor/CCB combination therapyJ Hum Hypertens200923778518685606
   PubMed Web of Science ®Google Scholar
• RubioAFLozanoJJVargasGRodríguezLRamosLMEscalanteBEfficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapyClin Exp Hypertens20062861962417060060
   PubMed Web of Science ®Google Scholar
• VerdecchiaPReboldiGAngeliFAngiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke preventionHypertension20054638639216009786
   PubMed Web of Science ®Google Scholar
• LlenenFHNwachukuCHBlackHRClinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialHypertension20064837438416864749
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med20083592417242819052124
   PubMed Web of Science ®Google Scholar
• DahlöfBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trialLancet200536689590616154016
   PubMed Web of Science ®Google Scholar
• PepineCJHandbergEMCooper-DeHoffRMfor the INVEST InvestigatorsA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease (INVEST): a randomized controlled trialJAMA20032902805281614657064
   PubMed Web of Science ®Google Scholar
• RubioAFArceoALozanoJJVargasGRodríguezLRamosLMEfficacy of a fixed-dose combination of trandolapril-verapamil in patients with stage-2 hypertension inadequately controlled by monotherapyClin Drug Invest200525445451
   Web of Science ®Google Scholar
• FogariRMalamaniGDZoppiAMugelliniARinaldiAVanasiaAEffect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertyensive patientsJ Hum Hypertens20031720721212624612
   PubMed Web of Science ®Google Scholar
• ParatiGOptimization of hypertension management: The role of angiotensin receptor blocker-calcium channel blocker combinationsJ Cardiovasc Pharmacol20095335235819365281
   PubMed Web of Science ®Google Scholar
• PoldermansDGlazerRKaragiannisSTolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertensionClin Ther20072927928917472820
   PubMed Web of Science ®Google Scholar
• AllemanYFraileBLambertMBarbierMFerberPHIzzoJLPrevious monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) StudyJ Clin Hypertens (Greenwich)20081018519418326958
   PubMed Web of Science ®Google Scholar
• ChrysantSGMelinoMKarkiSThe combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized double-blind, placebo-controlled, 8-week factorial efficacy and safety studyClin Ther20083058760418498909
   PubMed Web of Science ®Google Scholar
• LittlejohnTWMajulCROlveraRResults of treatment with telmisartan-amlodipine in hypertensive patientsJ Clin Hypertens (Greenwich)20091120721319614805
   PubMed Web of Science ®Google Scholar
• SchmiederREPhilippTGuerediagaJLong-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren. A 12-Month randomized, double-blind comparator trial with hydrochlorothiazideCirculation200911941742519139391
   PubMed Web of Science ®Google Scholar
• LittlejohnTWTrenkwalderPHollandersGZhaoYLiaoWLong-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertensionCurr Med Res Opin20092595195919257800
   PubMed Web of Science ®Google Scholar
• GasicSWagnerOFaschingPFosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type 2 diabetic patients with microalbuminuriaAm J Hypertens19991221722210090351
   PubMed Web of Science ®Google Scholar
• ParkJKFiebelerAMullerDNLacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injuryHypertension200239680689
   Web of Science ®Google Scholar
• SiragyHMXueChWebbRLBeneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-α production after cardiac ischemiaJ Cardiovasc Pharmacol20064763664216775501
   PubMed Web of Science ®Google Scholar
• Rubio-GuerraAFVargas-RoblesHVargas-AyalaGRodríguez-LopezLEscalante-AcostaBAThe effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetesClin Exp Hypertens20083068268818855271
   PubMed Web of Science ®Google Scholar
• RubioAFVargasHLozanoJJEscalanteBACorrrelation between circulating adhesión molecules levels and albuminuria in type 2 diabetic hypertensive patientsKidney Blood Press Res20093210610919342863
   PubMed Web of Science ®Google Scholar
• BakrisGLMolitchMHewkinADifferences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndromeDiabetes Care2006292592259717130190
   PubMed Web of Science ®Google Scholar
• BakrisGLMolitchMSowersJReversal of new onset diabetes by nondiuretic based fixed-dose antihypertensive drug combinations. Results of STAR 6-month extension (STAR-LET)J Cardiomet Syndr200831825
   PubMedGoogle Scholar
• RubioAFArceoAVargasGRodríguezLLozanoJTreviñoCThe Effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetesDiabetes Care2004271688169115220247
   PubMed Web of Science ®Google Scholar
• Rubio-GuerraAFVargas-RoblesHVargas-AyalaGRodríguez-LopezLEscalante-AcostaBAThe effect of trandolapril and its fixed-dose combination with verapamil on resistin levels in hypertensive patients with type 2 diabetesJ Hypertens200826S476
   Web of Science ®Google Scholar
• TakataYOsawaHKurataMHyperresistinemia is associated with coexistence of hypertension and type 2 diabetesHypertension20085153453918180399
   PubMed Web of Science ®Google Scholar
• Roca-CusachsASchmiederRETriposkiadisFEfficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetesJ Hypertens20082681381818327093
   PubMed Web of Science ®Google Scholar
• TattiPGuariscoRPahorMOutcome results of the Fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDMDiabetes Care1998215976029571349
   PubMed Web of Science ®Google Scholar
• WinerNFolkerAMurphyJAEffect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetesPrev Cardiol20058879215860983
   PubMedGoogle Scholar
• GrossJLDe AzevedoMJSilveiroSPDiabetic nephropathy: diagnosis, prevention and treatmentDiabetes Care200528176188
   Web of Science ®Google Scholar
• BakrisGLWeirMRSecicMCampbellBWeis-McNultyADifferential effects of calcium antagonist subclasses on markers of nephropathy progressionKidney Int2004651991200215149313
   PubMed Web of Science ®Google Scholar
• BakrisGWeirMRDeQuatroVMc-MahonFGEffects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathyKidney Int199854128312899767545
   PubMed Web of Science ®Google Scholar
• RubioAFTreviñoCJVargasGNarváezJLLozanoJJRodríguezLRenoprotective effects of the combination trandolapril/verapamil in patients with type 2 diabetes mellitus and hypertensionClin Drug Invest200222541546
   Web of Science ®Google Scholar
• RuggenentiPFassiAIlievaAPPreventing microalbuminuria in type 2 diabetic patientsN Engl J Med20043511941195115516697
   PubMed Web of Science ®Google Scholar
• JasikMNiebiszABKosiorDAKarnafelWNephroprotective effect of trandolapril and verapamil in normotensive type 1 diabetics – a 12-month follow-up studyDiabetologia Do wiadczalna i Kliniczna20066610
   Google Scholar
• BakrisGLTotoRDMcCulloughPATochaRPurkayasthaDDavisPOn behalf of the GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study InvestigatorsEffects of different ACE inhibitor combinations on albuminuria: results of the GUARD studyKidney Int2008731303130918354383
   PubMed Web of Science ®Google Scholar
• FogariRPretiPZoppiAEffects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patientsAm J Hypertens2002151042104912460699
   PubMed Web of Science ®Google Scholar
• TotoRDTianMFakouhiKChampionABacherPEffects of calcium channel blockers on proteinuria in patients with diabetic nephropathyJ Clin Hypertens (Greenwich)20081076176919090877
   PubMed Web of Science ®Google Scholar
• BoeroRRollinoCMassaraCBertoIMPerosaPVagelliGThe verapamil versus amlodipine in nondiabetic nephropathies treated with Trandolapril (VVANNTT) studyAm J Kidney Dis200342677512830458
   PubMed Web of Science ®Google Scholar
• GiuntiSCooperMManagement strategies for patients with hypertension and diabetes: why combination therapy is criticalJ Clin Hypertens (Greenwich)2006810811316470079
   PubMedGoogle Scholar
• MannJFSchmiederREMcQueenMDyalLSchumacherHRenal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialLancet200837254755318707986
   PubMed Web of Science ®Google Scholar
• BangaloreSKamalakkannanGParkarSMesserliFHFixed-dose combinations improve compliance: a meta-analysisAm J Med200712071371917679131
   PubMed Web of Science ®Google Scholar